Publication: Membrane PD-L1 expression and soluble PD-L1 plasma levels in idiopathic pulmonary fibrosis-a pilot study
| dc.contributor.author | Jovanovic, Dragana (58721901700) | |
| dc.contributor.author | Milenkovic, Marina Roksandic (56157719200) | |
| dc.contributor.author | Stevuljevic, Jelena Kotur (36629424300) | |
| dc.contributor.author | Markovic, Jelena (54793088700) | |
| dc.contributor.author | Ceriman, Vesna (57204881031) | |
| dc.contributor.author | Kontic, Milica (43761339600) | |
| dc.contributor.author | Trifunovic, Vesna Skodric (35273464900) | |
| dc.date.accessioned | 2025-06-12T15:40:21Z | |
| dc.date.available | 2025-06-12T15:40:21Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | Background: Idiopathic pulmonary fibrosis (IPF) has common risk factors with cancer and significant similarities in the pathobiology process, both diseases having poor outcomes. Immune checkpoint PD-L1 has become the target of checkpoint inhibitory therapy that unleashes antitumor T cells and has revolutionized cancer treatment. This is a pilot study exploring membrane immune checkpoint PD-L1 expression in human IPF lung tissue samples and its soluble form, soluble PD-L1 (sPD-L1) plasma concentrations in IPF patients, in order to investigate potential role of PD-L1 as an IPF biomarker. © Journal of Thoracic Disease. All rights reserved. | |
| dc.identifier.uri | https://doi.org/10.21037/jtd.2018.11.16 | |
| dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059540040&doi=10.21037%2fjtd.2018.11.16&partnerID=40&md5=e388e68d9631afc2d6c9296b3e83e8f4 | |
| dc.identifier.uri | https://remedy.med.bg.ac.rs/handle/123456789/5961 | |
| dc.subject | Idiopathic pulmonary fibrosis (IPF) | |
| dc.subject | Membrane PD-L1 expression | |
| dc.subject | Soluble PD-L1 | |
| dc.title | Membrane PD-L1 expression and soluble PD-L1 plasma levels in idiopathic pulmonary fibrosis-a pilot study | |
| dspace.entity.type | Publication |